carlyle is a global investment firm with $325 billion of assets under management. our purpose is to invest wisely and create value on behalf of our investors, portfolio companies and the communities in which we live and invest. founded in 1987 in washington, dc, carlyle has grown into one of the world’s largest and most successful global investment firms, with nearly 1,850 people operating in 26 offices across five continents.
Company profile
Ticker
CG, CG-MM
Exchange
Website
CEO
William E. Conway, Jr.
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Carlyle Group L.P.
SEC CIK
Corporate docs
Subsidiaries
Abingworth Bioventures 8 GP LP • Abingworth Bioventures GP Limited • Abingworth Bioventures V GP limited • Abingworth CCD GP Limited • Abingworth Clinical Co-Development Fund 2 GP LP • Abingworth German Designated LP Corp. • Abingworth Management Inc • Abingworth Second Partner Limited • ACP 2021 Agg. GP, LLC • ACP 2022 Agg. GP, LLC ...
IRS number
452832612
SEC advisor number
801-52462
FINRA CRD number
111128
AUM ?
$143.79 bn
(as of 29 Mar 20)
Accounts
561
(as of 29 Mar 20)
Employees
864
(286 investment advisory or research)
Address
Carlyle Group Inc
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVENUE, N.W.
WASHINGTON
DC 20004
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVENUE, N.W.
WASHINGTON
DC 20004
Phone
202 729 5626
CG stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
31 May 24
10-Q
2024 Q1
Quarterly report
7 May 24
ARS
2023 FY
Annual report to shareholders
18 Apr 24
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
PRE 14A
Preliminary proxy
3 Apr 24
8-K
Carlyle Appoints Afsaneh M. Beschloss as an Independent Director
3 Apr 24
8-K
Carlyle Names Lindsay LoBue as Chief Operating Officer
27 Mar 24
8-K
Carlyle Reports Fourth Quarter and Full-Year 2023 Financial Results
7 Feb 24
8-K
Departure of Directors or Certain Officers
18 Jan 24
Transcripts
CG
Earnings call transcript
2024 Q1
1 May 24
CG
Earnings call transcript
2023 Q4
7 Feb 24
CG
Earnings call transcript
2023 Q3
7 Nov 23
CG
Earnings call transcript
2023 Q2
2 Aug 23
CG
Earnings call transcript
2023 Q2
2 Aug 23
CG
Earnings call transcript
2023 Q1
4 May 23
CG
Earnings call transcript
2022 Q4
7 Feb 23
CG
Earnings call transcript
2022 Q3
8 Nov 22
CG
Earnings call transcript
2022 Q2
28 Jul 22
CG
Earnings call transcript
2022 Q1
28 Apr 22
Latest ownership filings
4
HARVEY M SCHWARTZ
23 May 24
4
Jeffrey W. Ferguson
23 May 24
4
Christopher Finn
23 May 24
4
Charles Elliott Jr. Andrews
23 May 24
4
John C. Redett
23 May 24
SC 13D/A
QuidelOrtho Corp
14 May 24
SC 13D/A
eFFECTOR Therapeutics, Inc.
13 May 24
4
Derica W Rice
3 May 24
4
ANTHONY WELTERS
3 May 24
4
LAWTON W FITT
3 May 24
Financial summary
Quarter (USD) | Mar 24 | Sep 23 | Jun 23 | Mar 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.28 bn | 1.28 bn | 1.28 bn | 1.28 bn | 1.28 bn | 1.28 bn |
Cash burn (monthly) | (no burn) | 6.97 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 14.78 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 1.26 bn | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 181.3 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
93.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 496 |
Opened positions | 170 |
Closed positions | 47 |
Increased positions | 139 |
Reduced positions | 114 |
13F shares | Current |
---|---|
Total value | 8.35 tn |
Total shares | 336.38 mm |
Total puts | 1.08 mm |
Total calls | 2.12 mm |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
Carlyle Group Management L.L.C. | 140.83 mm | $6.42 bn |
BLK Blackrock | 23.37 mm | $1.10 tn |
Vanguard | 23.33 mm | $1.09 tn |
Capital World Investors | 20.05 mm | $940.69 bn |
MS Morgan Stanley | 13.25 mm | $621.56 bn |
William Blair Investment Management | 11.82 mm | $554.45 bn |
STT State Street | 8.07 mm | $378.66 bn |
Vulcan Value Partners | 7.79 mm | $365.40 mm |
Ariel Investments | 4.88 mm | $229.06 bn |
Beutel, Goodman & Co | 4.32 mm | $202.50 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 May 24 | John C. Redett | Common Stock | Grant | Acquire A | No | No | 0 | 3,458 | 0.00 | 980,809 |
21 May 24 | Christopher Finn | Common Stock | Grant | Acquire A | No | No | 0 | 3,458 | 0.00 | 1,917,572 |
21 May 24 | Charles Elliott Jr. Andrews | Common Stock | Grant | Acquire A | No | No | 0 | 176 | 0.00 | 144,884 |
21 May 24 | Jeffrey W. Ferguson | Common Stock | Grant | Acquire A | No | No | 0 | 896 | 0.00 | 1,310,545 |
21 May 24 | Harvey M Schwartz | Common Stock | Grant | Acquire A | No | No | 0 | 44,052 | 0.00 | 7,042,876 |
News
Looking Into Carlyle Group's Recent Short Interest
29 May 24
Nvidia-Backed AI Firm CoreWeave Secures $7.5B In Debt Financing: Report
17 May 24
Recap: Carlyle Group Q1 Earnings
14 May 24
Jefferies Maintains Hold on Carlyle Group, Lowers Price Target to $44
9 May 24
Barclays Maintains Overweight on Carlyle Group, Lowers Price Target to $47
2 May 24
Press releases
Zippy Shell Inc. Completes $525 million Capital Raise
14 May 24
Carlyle Secured Lending, Inc. Announces Financial Results For First Quarter Ended 2024, Declares Second Quarter 2024 Dividends of $0.47 Per Common Share
7 May 24
Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission
2 May 24
OHA is Administrative Agent & Lead Left Arranger for Acentra Health's Private Refinancing
15 Apr 24
Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its First Quarter Ended March 31, 2024 Financial Results
11 Apr 24